A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein.

Developing antiviral therapies for influenza A virus (IAV) infection is an ongoing process because of the rapid rate of antigenic mutation and the emergence of drug-resistant viruses. The ideal strategy is to develop drugs that target well-conserved, functionally restricted, and unique surface struc...

Full description

Bibliographic Details
Main Authors: Michinori Kakisaka, Yutaka Sasaki, Kazunori Yamada, Yasumitsu Kondoh, Hirokazu Hikono, Hiroyuki Osada, Kentaro Tomii, Takehiko Saito, Yoko Aida
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-07-01
Series:PLoS Pathogens
Online Access:http://europepmc.org/articles/PMC4519322?pdf=render
id doaj-bd558cf880da4eb8a4a1eb2d8ec82d66
record_format Article
spelling doaj-bd558cf880da4eb8a4a1eb2d8ec82d662020-11-24T22:10:38ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742015-07-01117e100506210.1371/journal.ppat.1005062A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein.Michinori KakisakaYutaka SasakiKazunori YamadaYasumitsu KondohHirokazu HikonoHiroyuki OsadaKentaro TomiiTakehiko SaitoYoko AidaDeveloping antiviral therapies for influenza A virus (IAV) infection is an ongoing process because of the rapid rate of antigenic mutation and the emergence of drug-resistant viruses. The ideal strategy is to develop drugs that target well-conserved, functionally restricted, and unique surface structures without affecting host cell function. We recently identified the antiviral compound, RK424, by screening a library of 50,000 compounds using cell-based infection assays. RK424 showed potent antiviral activity against many different subtypes of IAV in vitro and partially protected mice from a lethal dose of A/WSN/1933 (H1N1) virus in vivo. Here, we show that RK424 inhibits viral ribonucleoprotein complex (vRNP) activity, causing the viral nucleoprotein (NP) to accumulate in the cell nucleus. In silico docking analysis revealed that RK424 bound to a small pocket in the viral NP. This pocket was surrounded by three functionally important domains: the RNA binding groove, the NP dimer interface, and nuclear export signal (NES) 3, indicating that it may be involved in the RNA binding, oligomerization, and nuclear export functions of NP. The accuracy of this binding model was confirmed in a NP-RK424 binding assay incorporating photo-cross-linked RK424 affinity beads and in a plaque assay evaluating the structure-activity relationship of RK424. Surface plasmon resonance (SPR) and pull-down assays showed that RK424 inhibited both the NP-RNA and NP-NP interactions, whereas size exclusion chromatography showed that RK424 disrupted viral RNA-induced NP oligomerization. In addition, in vitro nuclear export assays confirmed that RK424 inhibited nuclear export of NP. The amino acid residues comprising the NP pocket play a crucial role in viral replication and are highly conserved in more than 7,000 NP sequences from avian, human, and swine influenza viruses. Furthermore, we found that the NP pocket has a surface structure different from that of the pocket in host molecules. Taken together, these results describe a promising new approach to developing influenza virus drugs that target a novel pocket structure within NP.http://europepmc.org/articles/PMC4519322?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Michinori Kakisaka
Yutaka Sasaki
Kazunori Yamada
Yasumitsu Kondoh
Hirokazu Hikono
Hiroyuki Osada
Kentaro Tomii
Takehiko Saito
Yoko Aida
spellingShingle Michinori Kakisaka
Yutaka Sasaki
Kazunori Yamada
Yasumitsu Kondoh
Hirokazu Hikono
Hiroyuki Osada
Kentaro Tomii
Takehiko Saito
Yoko Aida
A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein.
PLoS Pathogens
author_facet Michinori Kakisaka
Yutaka Sasaki
Kazunori Yamada
Yasumitsu Kondoh
Hirokazu Hikono
Hiroyuki Osada
Kentaro Tomii
Takehiko Saito
Yoko Aida
author_sort Michinori Kakisaka
title A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein.
title_short A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein.
title_full A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein.
title_fullStr A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein.
title_full_unstemmed A Novel Antiviral Target Structure Involved in the RNA Binding, Dimerization, and Nuclear Export Functions of the Influenza A Virus Nucleoprotein.
title_sort novel antiviral target structure involved in the rna binding, dimerization, and nuclear export functions of the influenza a virus nucleoprotein.
publisher Public Library of Science (PLoS)
series PLoS Pathogens
issn 1553-7366
1553-7374
publishDate 2015-07-01
description Developing antiviral therapies for influenza A virus (IAV) infection is an ongoing process because of the rapid rate of antigenic mutation and the emergence of drug-resistant viruses. The ideal strategy is to develop drugs that target well-conserved, functionally restricted, and unique surface structures without affecting host cell function. We recently identified the antiviral compound, RK424, by screening a library of 50,000 compounds using cell-based infection assays. RK424 showed potent antiviral activity against many different subtypes of IAV in vitro and partially protected mice from a lethal dose of A/WSN/1933 (H1N1) virus in vivo. Here, we show that RK424 inhibits viral ribonucleoprotein complex (vRNP) activity, causing the viral nucleoprotein (NP) to accumulate in the cell nucleus. In silico docking analysis revealed that RK424 bound to a small pocket in the viral NP. This pocket was surrounded by three functionally important domains: the RNA binding groove, the NP dimer interface, and nuclear export signal (NES) 3, indicating that it may be involved in the RNA binding, oligomerization, and nuclear export functions of NP. The accuracy of this binding model was confirmed in a NP-RK424 binding assay incorporating photo-cross-linked RK424 affinity beads and in a plaque assay evaluating the structure-activity relationship of RK424. Surface plasmon resonance (SPR) and pull-down assays showed that RK424 inhibited both the NP-RNA and NP-NP interactions, whereas size exclusion chromatography showed that RK424 disrupted viral RNA-induced NP oligomerization. In addition, in vitro nuclear export assays confirmed that RK424 inhibited nuclear export of NP. The amino acid residues comprising the NP pocket play a crucial role in viral replication and are highly conserved in more than 7,000 NP sequences from avian, human, and swine influenza viruses. Furthermore, we found that the NP pocket has a surface structure different from that of the pocket in host molecules. Taken together, these results describe a promising new approach to developing influenza virus drugs that target a novel pocket structure within NP.
url http://europepmc.org/articles/PMC4519322?pdf=render
work_keys_str_mv AT michinorikakisaka anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
AT yutakasasaki anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
AT kazunoriyamada anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
AT yasumitsukondoh anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
AT hirokazuhikono anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
AT hiroyukiosada anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
AT kentarotomii anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
AT takehikosaito anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
AT yokoaida anovelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
AT michinorikakisaka novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
AT yutakasasaki novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
AT kazunoriyamada novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
AT yasumitsukondoh novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
AT hirokazuhikono novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
AT hiroyukiosada novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
AT kentarotomii novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
AT takehikosaito novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
AT yokoaida novelantiviraltargetstructureinvolvedinthernabindingdimerizationandnuclearexportfunctionsoftheinfluenzaavirusnucleoprotein
_version_ 1725807352429412352